Spots Global Cancer Trial Database for peritoneal mesothelioma
Every month we try and update this database with for peritoneal mesothelioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays | NCT02834234 | Peritoneal Meso... | comparative gen... | 18 Years - | Hospices Civils de Lyon | |
Intraperitoneal MCY-M11 (Mesothelin-targeting CAR) for Treatment of Advanced Ovarian Cancer and Peritoneal Mesothelioma | NCT03608618 | Peritoneal Meso... Fallopian Tube ... Adenocarcinoma ... Primary Periton... | MCY-M11 Cyclophosphamid... | 18 Years - | MaxCyte, Inc. | |
Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma | NCT03867578 | Mesothelioma Peritoneal Meso... | HR-MRI Standard CT Ima... Ultrasound | 18 Years - | University of Chicago | |
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma | NCT05041062 | Mesothelioma Peritoneal Meso... | Nivolumab Ipilimumab | 18 Years - | University of Chicago | |
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed | NCT01617382 | Peritoneal Carc... Pseudomyxoma Pe... Peritoneal Meso... | - | Universitaire Ziekenhuizen KU Leuven | ||
French National Registry of Rare Peritoneal Surface Malignancies | NCT02834169 | Rare Peritoneal... Pseudomyxoma Pe... Peritoneal Meso... Desmoplastic Sm... Psammocarcinoma Primary Periton... Diffuse Periton... Appendiceal Muc... | Non interventio... | - | Hospices Civils de Lyon | |
Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) | NCT03875144 | Peritoneal Meso... Peritoneal Carc... | PIPAC Cisplatin Pemetrexed | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers | NCT05337735 | Microsatellite ... Peritoneal Meso... Extrapulmonary ... Neuroendocrine ... Cervical Carcin... Hodgkin's Lymph... Pleural Mesothe... Small Cell Lung... | XmAb20717 | 18 Years - | M.D. Anderson Cancer Center | |
Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) | NCT03875144 | Peritoneal Meso... Peritoneal Carc... | PIPAC Cisplatin Pemetrexed | 18 Years - | Institut du Cancer de Montpellier - Val d'Aurelle | |
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma | NCT00996385 | Mesothelioma | Velcade (bortez... | 18 Years - | Columbia University | |
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy | NCT01160458 | Pleural Mesothe... Peritoneal Meso... | IMC-A12 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C | NCT02040142 | Peritoneal Carc... Colorectal Canc... Appendiceal Can... Peritoneal Meso... Pseudomyxoma Pe... Gastric Cancer | HIPEC Mitomycin C | 18 Years - | Albert Einstein College of Medicine | |
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma | NCT05041062 | Mesothelioma Peritoneal Meso... | Nivolumab Ipilimumab | 18 Years - | University of Chicago | |
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy | NCT01160458 | Pleural Mesothe... Peritoneal Meso... | IMC-A12 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma | NCT00402766 | Mesothelioma | Cisplatin Imatinib Mesyla... Pemetrexed Dexamethasone | 18 Years - | M.D. Anderson Cancer Center |